In high-risk patients, both were shown to reduce the chances of hospitalization or death from COVID-19, although Pfizer’s was much more effective.A closer look: WHO SHOULD TAKE THESE PILLS?...
That includesolder people and those with other health conditionslike heart disease, cancer or diabetes that make them more vulnerable....
Both pills were OK’d for adults while Paxlovid is authorized for children ages 12 and older. WHO SHOULDN’T TAKE THESE PILLS?...
综合
芝加哥论坛报-国家与世界
2021-12-27 00:00:00.0